Access to device-aided therapies in advanced Parkinson's disease: navigating clinician biases, patient preference, and prognostic uncertainty

M Auffret, D Weiss, F Stocchi, M Vérin… - Journal of Neural …, 2023 - Springer
Abstract Device-aided therapies (DAT), which include deep brain stimulation and pump-
based continuous dopaminergic stimulation with either levodopa or apomorphine, are …

A systematic review of health disparities research in deep brain stimulation surgery for Parkinson's disease

AA Memon, K Gelman, J Melott, R Billings… - Frontiers in Human …, 2023 - frontiersin.org
Background Deep brain stimulation (DBS) is the primary surgical intervention for Parkinson's
disease (PD) patients with insufficient response to medication, significantly improving motor …

Trends and disparities in deep brain stimulation utilization in the United States: a Nationwide Inpatient Sample analysis from 1993 to 2017

C Sarica, CR Conner, K Yamamoto, A Yang… - The Lancet Regional …, 2023 - thelancet.com
Background Deep brain stimulation (DBS) is an approved treatment option for Parkinson's
Disease (PD), essential tremor (ET), dystonia, obsessive-compulsive disorder and epilepsy …

The importance of digital health literacy in an evolving Parkinson's disease care system

CD Esper, BY Valdovinos… - Journal of Parkinson's …, 2024 - content.iospress.com
Digital health technologies are growing at a rapid pace and changing the healthcare
landscape. Our current understanding of digital health literacy in Parkinson's disease (PD) is …

Deep brain stimulation in PD: risk of complications, morbidity, and hospitalizations: a systematic review

MC Olson, H Shill, F Ponce, S Aslam - Frontiers in Aging …, 2023 - frontiersin.org
Introduction Parkinson's disease (PD) is a progressive and debilitating neurological
disorder. While dopaminergic medication improves PD symptoms, continued management …

Healthcare disparities in deep brain stimulation access and utilization: a systematic review

N Deshpande, M Hadi, R Ali - Journal of Neurosurgery, 2023 - thejns.org
OBJECTIVE Since FDA approval of deep brain stimulation (DBS) for essential tremor over 2
decades ago, indications and utilization of this modality have rapidly expanded worldwide …

Black and hispanic patients with movement disorders less likely to undergo deep brain stimulation

A Dorritie, M Faysel, A Gruessner, D Robakis - Parkinsonism & Related …, 2023 - Elsevier
Background DBS is an effective surgical treatment for ET, PD, and dystonia. Racial
disparities in DBS utilization in PD have been documented demonstrating that Black patients …

Development of a remote therapeutic monitoring platform: applications for movement disorders

S Thankathuraipandian, W Greenleaf, A Kyani… - Scientific Reports, 2024 - nature.com
Digital health tools are emerging as a promising solution for optimizing Deep Brain
Stimulation (DBS) therapy for neurodegenerative diseases such as Parkinson's Disease …

Racial disparities in access to DBS: results of a real-world US claims data analysis

M Frassica, DS Kern, M Afshari, AT Connolly… - Frontiers in …, 2023 - frontiersin.org
Introduction Deep brain stimulation (DBS) is an effective and standard-of-care therapy for
Parkinson's Disease and other movement disorders when symptoms are inadequately …

Disparities in the treatment of movement disorders using deep brain stimulation

V Venkatraman, BG Futch, KJB Padron, LZ Yang… - Journal of …, 2024 - thejns.org
OBJECTIVE Deep brain stimulation (DBS) is a well-established treatment for Parkinson's
disease (PD) and essential tremor (ET). Although the prevalence of PD and ET can vary by …